Biomerieux Valuation
| BIM Stock | EUR 100.70 0.70 0.69% |
At this time, the firm appears to be overvalued. Biomerieux SA shows a prevailing Real Value of €87.59 per share. The current price of the firm is €100.7. Our model approximates the value of Biomerieux SA from analyzing the firm fundamentals such as Return On Equity of 0.18, profit margin of 0.16 %, and Current Valuation of 11.4 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Biomerieux's price fluctuation is very steady at this time. Calculation of the real value of Biomerieux SA is based on 3 months time horizon. Increasing Biomerieux's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Biomerieux SA is useful when determining the fair value of the Biomerieux stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Biomerieux. Since Biomerieux is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomerieux Stock. However, Biomerieux's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 100.7 | Real 87.59 | Hype 100.7 | Naive 96.96 |
The real value of Biomerieux Stock, also known as its intrinsic value, is the underlying worth of Biomerieux SA Company, which is reflected in its stock price. It is based on Biomerieux's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Biomerieux's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biomerieux's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biomerieux SA helps investors to forecast how Biomerieux stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomerieux more accurately as focusing exclusively on Biomerieux's fundamentals will not take into account other important factors: Biomerieux Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Biomerieux's current stock value. Our valuation model uses many indicators to compare Biomerieux value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomerieux competition to find correlations between indicators driving Biomerieux's intrinsic value. More Info.Biomerieux SA is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.09 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biomerieux SA is roughly 10.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomerieux by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomerieux's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomerieux's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biomerieux's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biomerieux and how it compares across the competition.
About Biomerieux Valuation
The stock valuation mechanism determines the current worth of Biomerieux SA on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Biomerieux SA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Biomerieux SA based exclusively on its fundamental and basic technical indicators. By analyzing Biomerieux's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biomerieux's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biomerieux. We calculate exposure to Biomerieux's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biomerieux's related companies.bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people.
8 Steps to conduct Biomerieux's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biomerieux's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biomerieux's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biomerieux's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biomerieux's revenue streams: Identify Biomerieux's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biomerieux's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biomerieux's growth potential: Evaluate Biomerieux's management, business model, and growth potential.
- Determine Biomerieux's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biomerieux's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerieux SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Biomerieux Stock analysis
When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |